Would still like to hear Dr. P on a call. I added that to my question in the chat pod in that "His knowledge and insight adds a lot of credibility to Leronlimab which I have found extremely important as a shareholder."Not a great start to the call, but some interesting information was given. Maybe not saying much, but it seems better than past webinars. Plus, got the Dr. P question answered.
I know a little bit about NERV ...People drank their coffee.
I was immensely tempted to throw a hefty amount into NERV when it was like 2.50 the other day.
Might even be tempted to dabble at 3.80 here. I know nothing of the company
What was the answer?Not a great start to the call, but some interesting information was given. Maybe not saying much, but it seems better than past webinars. Plus, got the Dr. P question answered.
Dr. Patterson is hard at work in his lab working on the results of the two clinical trials. Trials are now scheduled to end June 15 with the goal of getting the data presented two weeks later.What was the answer?
I'm out now too. Thanks for the heads-up which will make my July mortgage payment too.It's a momentum trade. People see it trending up and everybody wants a piece on the way up.
I sold all of it with an average gain of 38%...will pay the July mortgage.
Kicking myself for not opening a larger position yesterday. Maybe I’ll buy a six pack.It's a momentum trade. People see it trending up and everybody wants a piece on the way up.
I sold all of it with an average gain of 38%...will pay the July mortgage.
To be fair, I got a pretty cheap mortgage right now. less than 25% of my monthly pay.Kicking myself for not opening a larger position yesterday. Maybe I’ll buy a six pack.
Like almost 100% cash?Just sold it “all”.
holding my CYDY and RGR.
its been a good run.
In the active account, yes.Like almost 100% cash?
my 3% trailing stop loss hit so I got out at 40ish%. I'll take it, but godspeed to you, sir!GNUS at +50% now. My position is so small that I may just stay in and see where it takes me. $9 or bust!!!
And being at 58 in the mild to moderate is good news. They said that they'll stop enrollment on June 15th regardless of how many are enrolled. I don't believe that. They should have at least 70 by that date. It seems shortsighted to not wait a few more days or a week to see it fully enrolled at 75. The FDA wants 75. We should do 75.Thought CYDY cc was very good.
News about Mexico very positive. Will only need to enroll 25 for trial instead of 300 some. Will allow CYDY to combine anecdotal results with trial results. Would expect Mexico to approve before US. This would open basically most latin american countries as well . NP has been in direct conversation with Mexico's Dr. Fauci equivalent.
My take on this, based on Dr. Jay's comments, is that they have seen data that shows the efficacy and waiting to get 12 more people is not going to add any statistical relevance. On June 15th they unblind and I assume, that based on the data they have seen, they think they already know who got Leronlimab and who got a placebo. Hopefully the data matches up with what they are expecting when they do unblind. I don't expect any statistical data until the end of June. I would not be surprised to see a webinar on the 16th where NP expects to hopefully release potentially good news maybe at the end of June.And being at 58 in the mild to moderate is good news. They said that they'll stop enrollment on June 15th regardless of how many are enrolled. I don't believe that. They should have at least 70 by that date. It seems shortsighted to not wait a few more days or a week to see it fully enrolled at 75.
So they've said in the past that there will be interim results 2 weeks after the initial 50 patients are enrolled in the severely ill phase 2b/3 trial. So will we get those interim results on June 15th? Nader mentioned today that at the end of June we'll get the 28 day results but it'll be nice to get some initial double blind results on June 15th. It sucks that his verbal skills are so pathetic that we're always having to decipher what he said and fill in the blanks.
They can say that but it doesn't mean it is true. My guess is that is their fallback strategy if we have around 65 enrolled at that point. If we have 70-74 enrolled at that point, we should wait to fully enroll it. They've said in the past it would be best to get the entire 75 because that is what the FDA has asked and wants. Hopefully, the point is moot because we have 75 on June 15th which is very realistic.My take on this, based on Dr. Jay's comments, is that they have seen data that shows the efficacy and waiting to get 12 more people is not going to add any statistical relevance.
Great minds. I just sold about half of what I shoveled into the S&P in the 2nd half of March. Moving back towards are more balanced allocation. Nice win.In the active account, yes.
active account is 30% overall.
You and me both.... my FOMO kicked in after watching this thing double over the last monthFinally got into draftkings. Bought shares a few times, lowest being at 40.01. I am mad at myself that I didnt buy any as soon as I knew the stock existed.
Stonks go up
You and me both.... my FOMO kicked in after watching this thing double over the last month
Great, I'll blame you guys for causing it to sell off instead of myself. I bought in as well.Finally got into draftkings. Bought shares a few times, lowest being at 40.01. I am mad at myself that I didnt buy any as soon as I knew the stock existed.
Stonks go up
Why would CYDY have any interest in partnering with big pharma once their data is published? Before, sure--take advantage of their expertise etc but after the data's been submitted? All the hard work's been done.Going over notes a couple of other things from CYDY cc.
NP was asked whether Dr. Fauci was aware of leronlimab. He indicated no but that FDA needed results from trials.
Covid trials will end June 15 regardless of number enrolled. Data will be analyzed then submitted to FDA at end of month.
CYDY not focused now on direct comparison trial to remdesivir.
THey will know at end of next week regarding Patterson's article publication in NEMJ
When asked about CYDY receiving govt grants. NP replied that their submission request would be finished soon.
CYDY will sign by tomorrow a non-binding distribution agreement with a major company. It was not explained what a non-binding agreement means.
NP said word of leronlimab is spreading as a cancer tx and they are getting many calls from people which will help them fill their basket trials.
Uplisting- NP said he was advised by legal to not discuss what exchange they are seeking to go with but believes they will be able to meet financial requirements
Regarding the investment bank agreement which he had earlier said would be signed this past weekend. NP said no bank had been selected yet and suggested they were being solicfited by several banks. NP said he could not discuss further due to legal.
Have not heard back from FDA on BLA submission but FDA has 60 days to reply.
Said he expects Big Pharma will want to partner once data released on trials
Both NP and Dr. Jay mentioned the efficacy of the drug which was demonstrated in EINDs before trials. Dr. Jay said that leronlimab will be a "home run" drug/
Except CYDYFinally got into draftkings. Bought shares a few times, lowest being at 40.01. I am mad at myself that I didnt buy any as soon as I knew the stock existed.
Stonks go up
HOLY CRAP!GNUS going nuts AH.
Me too. Bought 400 shares this morning at 310 and 315. Robinhooders must be loving this one.HOLY CRAP!
Again...wish I had put more into this one.
IWasn't clear what he meant as he included at the end of a thought. But my impression was that it might have something to due with distribution.Why would CYDY have any interest in partnering with big pharma once their data is published? Before, sure--take advantage of their expertise etc but after the data's been submitted? All the hard work's been done.
I put in an order to double my position at 2.95 this morning and barely missed the boat. Upped my limit to 3.10, then 3.20, and it just wouldn’t fill. Oh well.Me too. Bought 400 shares this morning at 310 and 315. Robinhooders must be loving this one.
And to think I didn't want to get in at $2.50 because of the run it had already had. I have so much to learn.Sheesh...and I was feeling good about my 38%
Hard work hasn’t been done. No one has contributed to the appropriate campaigns to get this drug approved.Why would CYDY have any interest in partnering with big pharma once their data is published? Before, sure--take advantage of their expertise etc but after the data's been submitted? All the hard work's been done.
@caustic where are you seeing this? Downloaded the app and it shows most popular stocks but not trading volume among its members.No surprise, GNUS was the most-added stock on Robinhood today. #2 was LTM, a bankrupt airline.
So how do we use this to our advantage?It’s on robintrack.net under “popularity changes.”
You don't. By the time you discover a trend, the pros have already been exploiting it.So how do we use this to our advantage?
It's down a little over 2% after hours.Wow, not sure what the stock will do tomorrow but ZM beat earnings expectations by 120% and beat the revenue expectations by 60%. The had great growth in the last quarter, 78%, but grew this past quarter by 169%. Normally, that type of beat would blowout the stock price but it’s been on such a tear, who knows.
Buy the rumor sell the news....It's down a little over 2% after hours.
Someone way smarter than me could probably figure it out but there are some features that allow you to see which stocks picked up the most users and which has the largest relative gains. You can look at that for days, week, or even 1 hour or four hours. When I looked at some of the top positive changes, there seems to be a flock of them chasing a trend up. Not sure how different this is than the broader market, but wondering if less seasoned investors might be more inclined to fuel some momentum stocks and be late to the party. Thinking about some comments here on DKNG and others where it felt too late but there was still a run there.So how do we use this to our advantage?
ManufactureWhy would CYDY have any interest in partnering with big pharma once their data is published? Before, sure--take advantage of their expertise etc but after the data's been submitted? All the hard work's been done.
I don't think marketing a therapeutic for COVID-19 will be tough in any way. Manufacturing and distribution are done. Lobbying? The data is in--if the FDA drags its heels, then they will have more blood on their hands.Manufacture
Distribution
Marketing
Lobbying